Intelligene Inc. (TPEX:7832)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
14.50
+0.10 (0.69%)
At close: Feb 26, 2026
202.08%
Market Cap 8.41B
Revenue (ttm) 3.36M
Net Income (ttm) -166.81M
Shares Out 580.00M
EPS (ttm) -0.32
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 390,889
Average Volume 616,994
Open 14.50
Previous Close 14.40
Day's Range 14.35 - 14.55
52-Week Range 4.73 - 17.65
Beta n/a
RSI 46.65
Earnings Date Apr 10, 2026

About Intelligene

Intelligene Inc. engages in the research and development of RNA gene therapy drugs in Taiwan and Australia. The company offers IG-001, a siRNA-based drug which is under preclinical trials for the treatment of coronavirus disease; and IG-002, a siRNA-based drug which is under drug screening for the treatment of influenza. It also provides lipid nanoparticle and exosome drug encapsulation technologies to customize drug carriers and develop nucleic acid therapeutics. The company was founded in 2023 and is based in Taipei, Taiwan. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2023
Employees 20
Stock Exchange Taipei Exchange
Ticker Symbol 7832
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.